Stocks · Health care · Pharmaceutical Preparations

Seres Therapeutics, Inc.

MCRB Clue Score46
United States Fiscal year ends December CIK 0001609809 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Kelly Brady
18 May 2026
See Remarks
Sell
59
$7.53
$444.27

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 8
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 13,636
History held since 29 Jun 2015